The intermediate lobe (IL) of the pituitary produces a PRL-regulating factor (PRF). Targeted tumorigenesis, using the POMC promoter ligated to SV40 large T antigen (Tag), generated transgenic mice that develop IL tumors with PRF activity. Our goal was to establish and characterize a PRF-producing cell line. Two cell lines, which differ markedly in size and morphology, were independently developed from IL tumors and designated mIL5 and mIL39. These cells are transformed, as judged by rapid proliferation, low serum requirements, and generation of secondary tumors in nude mice. RT-PCR revealed that mIL39, but not mIL5 cells, express POMC and dopamine D 2 receptors, typical of a melanotroph phenotype. Although mIL5 cells originated from an IL tumor, they do not express messenger RNA for SV40 Tag.
T HE MOUSE pituitary gland is composed of three distinct lobes. The predominant anterior pituitary (AP) contains a heterogenous population of hormone secreting cells of ectodermal origin and is devoid of nerve endings. The neural lobe (NL) is derived from the neuroectoderm and consists of hypothalamic neurosecretory terminals and pituicytes (astroglial cells). The much smaller intermediate lobe (IL) , juxtaposed between the two lobes, is primarily composed of POMC-producing melanotrophs. Like the AP, the IL develops from the oral cavity (Rathke's pouch) but differs from the AP by having rich innervation (1, 2) and poor vascularization (3) . Given the proximity of the IL to the NL, the combined tissue is often referred to as the neurointermediate lobe or posterior pituitary.
Recent evidence indicates that the IL participates in the regulation of PRL secretion. PRL release is modulated by both inhibitory and stimulatory factors that originate from the hypothalamus and pituitary (4, 5) . Whereas dopamine is well established as the primary inhibitor of PRL secretion (6) , the identity of the physiological stimulator of PRL release remains to be determined. Our laboratory has reported that an intact posterior pituitary is necessary for the suckling-and estradiol-induced rises in PRL (7, 8) , suggesting the presence of a PRL-regulating factor (PRF) in this tissue. This was supported by in vitro experiments demonstrating that PRF is a potent stimulator of both PRL gene expression (9, 10) and release (11, 12) and is distinct from other PRL secretagogues (12) (13) (14) . Cell separation on density gradients indicated that PRF is produced by a subpopulation of IL cells (15) .
The small size of the mammalian IL has hampered efforts to isolate and purify PRF. This impediment could be overcome by the availability of PRF-producing cells. Targeted tumorigenesis (16) and gene knockout strategies (17) (18) (19) have generated several lines of transgenic mice that develop IL tumors. In particular, the use of a transgene composed of a truncated POMC promoter ligated to the transforming simian virus 40 large T antigen (POMC-Tag) resulted in tumor formation exclusively in the IL (16) . We previously reported that primary tumors from heterozygous POMCTag mice, as well as secondary tumors developed in athymic nude mice, exhibited PRF activity that was distinct from known PRL secretagogues or POMC-derived products (14) . Given the time and expenses required for generating tumors of relatively small size, an enriched and renewable source of PRF was clearly needed. The objective of the present inves-tigation was to establish a PRF-producing cell line from such tumors and determine its cellular and biochemical characteristics.
Materials and Methods Animals
Mice. Transgenic mice were produced as previously described (16) at the Vollum Institute (Portland, OR). Heterozygote male mice from the F 22 generation were back crossed to female Swiss-Webster outbred stock (Harlan Industries, Indianapolis, IN), establishing a breeding colony at Cincinnati. At 22-28 days of age, DNA was extracted from tail clips and subjected to genotyping by PCR using primers for SV40 large T antigen (20) . Adult female athymic nu/nu mice (Harlan) were maintained individually in isolation cages and were used as hosts to generate secondary tumors.
Rats. Ovariectomized adult female Fischer 344 rats (Harlan) were used as donors of AP cells for the PRF bioassay. All animals were maintained under constant temperature with food and water ad libitum. Animal experimentation was performed under an institutionally approved protocol according to the USPHS Guide for the Care and Use of Laboratory Animals.
Primary and secondary tumors
Primary IL tumors began to develop between 6 -12 weeks of age in both male and female heterozygous mice. Mice bearing large tumors were easily recognized by lack of grooming and changes in the shape of the skull as the IL tumor expanded and displaced the brain. Mice were killed by cervical dislocation and the tumors aseptically removed. Portions of the tumors were either processed for histological examination or dispersed by trypsinization. The cells were placed in culture or injected sc into nude mice to generate secondary tumors. Approximately 1 ϫ 10 7 primary tumor cells were used for induction of secondary tumors, which developed as early as 20 days after inoculation.
Cell culture
mIL cell lines. Of more than 15 primary IL tumors placed in culture, cells from only two females, designated mIL5 and mIL39, remained viable. Repeated serial dilutions generated clonal cell lines that have been carried for over 70 passages. Cultures are maintained in RPMI 1640 medium supplemented with 10% FBS and penicillin-streptomycin (PenStrep; GIBCO-BRL, Gaithersburg, MD) at 37C under 5% CO 2 . Both mIL5 and mIL39 cells were used for the following: 1) generation of secondary tumors in nude mice; 2) determination of selected gene expression by RT-PCR; 3) assessment of PRF activity by coculturing with either GH 3 / luc cells or primary AP cells; 4) production of conditioned media (CM); and 5) morphological characterization following growth on glass chamber slides (LabTech, Naperville, IL).
Primary rat AP cells. Anterior pituitary glands were removed from ovariectomized Fischer 344 female rats and dispersed as previously described (21) . Cells were plated at a density of 10,000 cells per well (10K) in 96-well plates (NUNC, Copenhagen, Denmark) and cultured for three days in serum free medium (SFM) composed of DMEM/F10 medium (50/50; GIBCO-BRL) supplemented with 1% ITS ϩ Premix (Collaborative Research, Bedford, MA), 1% nonessential amino acids and Pen-Strep. The mIL cells were trypsinized, added to the AP cells, and cocultured for 3 additional days. Media were removed and analyzed for PRL and GH by RIA.
GH 3 /luc cells. GH 3 cells, obtained from the American Type Culture Collection (ATCC, Rockville, MD), were stably transfected with 2.5-kb rat PRL promoter ligated upstream of a firefly luciferase reporter gene as previously described (10, 22) . The GH 3 /luc cells were maintained in Ham's F-10 medium supplemented with 15% gelding serum and 50 g/ml geneticin (G418; Sigma Chemical Co, St. Louis, MO); basal luciferase activity remained stable for over 18 months. The GH 3 /luc cells were used to evaluate PRF activity as judged by both PRL gene expression and release as described below.
Cell proliferation
The growth rate of mIL5 and mIL39 cells was determined by the MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) assay as previously described (23) . Briefly, cells were plated at 5K cells per well in 96-well plates (NUNC) precoated with protamine (2.5 mg/ml; Sigma) and Nu-Serum (Collaborative Research) and cultured in RPMI 1640 medium containing 10% FBS. At the designated times, MTT (1 mg/ml; Sigma) was added and incubated for 3 h. After removal of the medium, 100 l of a developing solution (0.04 m HCl/isopropyl alcohol) were added and optical density at 540 nm was determined using a Dynatech (Chantilly, VA) MR700 Microplate Reader.
RT-PCR
Total RNA from cells and tissues was extracted by Tri Reagent (Molecular Research Center, Cincinnati, OH) and 5 g were reverse transcribed using Superscript II (GIBCO-BRL) and random hexamers as described (22) . PCR was performed on 10% of the RT product using the following primers: 1) POMC, sense primer 5Ј-TGCCGAGATTCTGC-TACAGTCG'3Ј and antisense 5Ј-GGAAGTGACCCATGACGTACTT-3Ј, with an expected product size of 246 bp; 2) Dopamine receptor (D 2 long and short), sense primer 5Ј-CGCAGCAGTCGAGCTTTCAGA-3Ј and antisense 5Ј-GCTCATCGTCTTAAGGGAGGT-3Ј with expected product sizes of 402 bp (long form) and 315 bp (short form); 3) estrogen receptor ␣ (ER␣), sense primer 5Ј-GGTCCAATTCTGACAATCGACG-3Ј and antisense 5Ј-CGTATCCCGCCTTTCATC-3Ј with an expected product size of 309 bp; 4) SV40 large T antigen (SV40 Tag), sense primer 5Ј-GCAATCGAAGCAGTAGCAATC-3Ј and antisense 5Ј-CAGCTAAT-GGACCTTCTAGG-3Ј with an expected product size of 395 bp. All PCR reactions also contained primers for the housekeeping gene ribosomal protein L19 (RPL19), sense primer 5Ј-AGTAGTCTTAGGCTACA-GAAG-3Ј and antisense 5Ј-TTCCTTGGTCTTAGACCTGCG-3Ј with an expected product size of 500 bp. All primer sets, except for SV40 Tag, were designed to span introns. Underlined nucleotides represent mismatches between mouse and rat sequences. For SV40 Tag, RNA was treated with DNase to remove contaminating DNA. Cycle conditions were: 94 C for 30 sec, 58 C for 30 sec, and 72 C for 30 sec for 32 cycles. Products were separated on a 1.5% agarose gel containing ethidium bromide and photographed.
Bioassay for PRF
PRL gene expression. GH 3 /luc cells (20K) were plated on protamine/ Nu-Serum-coated 96 well plates and incubated in SFM for 3 days. The cells were then washed and subjected to the following treatments: 1) coculture with mIL cells; 2) incubation with CM from mIL cells; 3) incubation with reconstituted HPLC fractions. After 18 h, media were removed for PRL and GH analysis by RIA and the cells were lysed by adding 50 l of lysis buffer (Promega, Madison WI). After incubation for 15 min at 37 C, 20-l aliquots in duplicate were transferred to black 96-well plates (Packard Instrument Co, Downers Grove, IL) and 80 l of luciferin (Promega) were added. Luciferase activity, as a measure of PRL gene expression, was quantitated by luminometry using a Packard TopCount.
PRL and GH release. The concentrations of PRL and GH in media from both GH 3 /luc and primary AP cells were determined by a modified RIA. NIDDK rat PRL and rat GH RIA kits with rPRL RP-3 and GH RP-2 as reference preparations, respectively, were used. Briefly, media aliquots were diluted in PBS containing 0.1% BSA in opaque white 96-well plates (Packard) to a final volume of 100 l. After adding 50 l each of primary antibody and iodinated hormone, the plates were incubated for 2 days at 4 C. Protein A (50 l) was then added and the plates centrifuged at 4000 ϫ g for 10 min. The supernatant was aspirated and the pellet dissolved in 20 l of 0.1 n NaOH followed by 200 l of scintillation fluid (Microscint 20, Packard). The plates were sealed with TopSeal (Packard) and after vigorous mixing, radioactivity was counted using a Packard TopCount.
HPLC fractionation
Approximately 18 ϫ 10 6 mIL5 cells were pelleted, washed with saline, and extracted by sonication in 1 n acetic acid. After freeze-thaw, extracts were centrifuged at 10,000 ϫ g for 20 min at 4 C. The supernatant was loaded on an analytical C-18 reversed phase column (4.6 mm ϫ 25 cm; Rainin, Woburn, MA) and fractionated with 0.1% trifluoroacetic acid at an increasing gradient of acetonitrile (AcN) from 0 -60% over 60 min at 1 ml/min as previously described (14) . One-milliliter fractions were collected and aliquots were pooled from every four fractions. After lyophilization, fractions were reconstituted in SFM and incubated with GH 3 /luc cells as described above.
Data analysis
All experiments were performed at least three times. PRF values are expressed as a percentage of control values, i.e. GH 3 /luc or primary AP cells incubated alone. Data were analyzed by ANOVA followed by Student's t test.
Results

Morphology and histology of primary and secondary tumors
Heterozygous mice expressing the POMC-Tag transgene developed tumors of the IL as previously described (16) . Figure 1 , top left panel compares a brain with attached pituitary from a wild-type mouse with two brains from transgenic animals with massive IL tumors. These tumors grow at an unpredictable rate and can become 100-fold larger than a whole pituitary. In spite of their massive size, the tumors do not appear to infiltrate the brain proper. At an advanced tumor stage, animals begin to lose weight and eventually die from complications caused by brain compression. The two females whose IL tumors are shown in Fig. 1 were 1 yr old at the time they were killed. A representative section of a primary IL tumor stained with hematoxylin and eosin (H&E) is shown in Fig. 1 , lower left panel. The cells are small and ovoid with prominent nuclei and variable cytoplasmic staining. The tumor is highly vascularized, as evident by the presence of blood vessels filled with red blood cells.
A nude female bearing a secondary tumor that was derived from the mIL5 cell line (passage 65), is shown in Fig.  1, upper right 
Cellular characteristics of the mIL cell lines
Although both mIL5 and mIL39 cells originated from primary IL tumors, they differ dramatically in size and morphology. The mIL5 cells, seen by phase contrast microscopy in Fig. 2A , are gigantic cells with numerous 
Differences in growth rate between mIL5 and mIL39
The growth rate of mIL5 and mIL39 cell lines was determined by the MTT colorimetric assay (Fig. 3) . Under the standard culture conditions (RPMI containing 10% FBS), the mIL5 cells have a fast doubling time of 15 h, whereas mIL39 cells double every 21 h. This growth rate remained relatively stable over a period of 6 -8 months. The cells also proliferate, albeit slower, under reduced serum conditions, e.g. 1% FBS.
Characterization of cell phenotype by RT-PCR
RT-PCR was used to determine whether both mIL cell types can be classified as melanotrophs, whose defining gene is POMC (24, 25) . As expected, POMC is expressed by the normal mouse pituitary (mAP) and by both primary IL tumors and secondary tumors derived from primary tumor cells (Fig. 4, upper panel) . However, of the two cell lines, only mIL39 expressed POMC. Further analysis for expression of SV40 Tag revealed that only mIL39, but not mIL5 cells, were positive for SV40 Tag (Fig. 4, lower panel) . Although mIL5 cells do not express SV40 Tag messenger RNA, they carry the 
POMC-Tag transgene, as judged by PCR of genomic DNA (data not shown).
Dopamine D 2 receptor expression differentiates IL melanotrophs from POMC-producing AP corticotrophs (26, 27) . As shown in Fig. 5 , upper panel, dopamine receptors are expressed by all samples examined except for mIL5. The long form of the D2 receptor predominates, but the short form (315 bp) is also weakly expressed by the same tissues. Since we previously reported that estrogen increases PRF activity in the IL (8, 22) , we examined the expression of estrogen receptors in these cells. As shown in Fig. 5, lower panel, ER␣ is expressed by all tested samples, except for rPP8, a newly developed rat posterior pituitary endothelial cell line (unpublished observation) that served as a negative control.
Comparison of PRF activity in mIL cell lines using GH 3 / luc cells
The advantage of the stably transfected GH 3 /luc cells as a bioassay for PRF is the concurrent measurement of both PRL gene expression and release. Coculturing mIL5 cells for 18 h with GH 3 /luc cells induced a significant cell density-dependent rise in luciferase gene activity (Fig. 6, left panel) . As few as 2. is a secreted product, 4 ϫ 10 5 mIL5 or mIL39 cells were grown in SFM and the CM collected after 3 days. As shown in Fig.  6 , right panel, 12.5, 25, and 50% CM from mIL5 cells induced 4-, 5-, and 10-fold increases in PRL gene expression, respectively. In contrast, at all concentrations tested, CM from mIL39 cells resulted in only 2-to 3-fold increases. The pattern of PRL release from the same GH 3 /luc cells paralleled the luciferase activity, supporting the presence of substantial PRF activity in mIL5, but not mIL39 cells (Fig. 7) . As determined by both rat and mouse PRL RIAs, PRL itself was undetectable in CM collected from either mIL5 or mIL39 cells. The release of GH was unchanged by coculture with mIL cells or by incubation with their CM (data not shown). Coculture of mIL cells with nontransfected GH 3 cells induced a similar rise in PRL release to that obtained using GH 3 /luc cells (data not shown).
PRF activity determined by coculturing mIL cells with primary rat AP cells
Coculture of mIL5 cells with primary rat AP cells for 3 days resulted in a cell density-dependent increase in PRL release (Fig. 8, upper panel) . PRF activity of mIL39 cells, compared with mIL5, was significantly lower (P Ͻ 0.01 at 20K). As evident, GH release from these cocultures was not significantly changed (Fig. 8, lower panel) , further supporting the hormonal specificity of PRF activity.
Resolution of PRF activity from mIL5 on reverse phase HPLC
Acetic acid extract of mIL5 cells was fractionated on an analytical C-18 reverse phase HPLC column and aliquots from pooled fractions were analyzed for PRF activity by incubation with GH 3 /luc cells. As shown in Fig. 9 , PRF activity resolved into a major peak at 45-48% AcN and a minor peak at 38 -40%. PRL release, both in elution pattern and magnitude, closely paralleled luciferase gene activation.
Discussion
We have successfully developed two cell lines from IL tumors of POMC-Tag transgenic mice. These cells are transformed, as judged by their fast doubling time, low serum requirement, and ability to generate secondary tumors in athymic nude mice. The two cell lines differ markedly in size, morphology, and biochemical characteristics. The mIL5 cell line produces and secretes PRF but does not possess classical melanotroph attributes. This supports and extends our previous report (14) that PRF is not a POMC-derived product. Surprisingly, these cells do not express Tag and appear to have been transformed by one or more spontaneous mutations. In contrast, mIL39 cells express both POMC and dopamine D 2 receptors, consistent with a melanotroph phenotype, but have weak PRF activity.
The mouse IL is a minute tissue that contains only 2 ϫ 10 5 cells (28) . Unlike most of its neighboring AP cells, IL cells maintain a robust proliferative capability, as evident by increased cell division in response to pituitary stalk section (3) or treatment with haloperidol (29) or interleukin-1␤ (30) . The IL expresses a very high density of D 2 receptors (26, 27) and dopamine exerts an inhibitory control over both POMC gene expression (29, 31) and melanotroph proliferation (32, 33) . Indeed, the onset of dopaminergic innervation of the IL in early postnatal life coincides with cessation of cellular proliferation (32) . Whether maintenance of a relatively constant number of IL cells during adulthood reflects a balance between proliferation and apoptosis, remains to be determined. A common strategy for targeted tumorigenesis is via transgenes encoding a transforming viral protein (e.g. SV40 Tag) under the transcriptional control of tissue-specific gene promoters. The rat 5Ј-flanking sequences (Ϫ706 to ϩ64) of the POMC gene used to generate the POMC-Tag transgenic mice appear insufficient for transcriptional activity in extrapituitary sites (34) . However, the reason for tumor formation in IL melanotrophs, but not AP corticotrophs, is not clear. Pre- sumably, SV40 Tag induces neoplastic transformation by binding to the protein products of the tumor suppressors p53 and retinoblastoma (Rb) genes (35) , which are involved in cell cycle regulation, differentiation and survival. It is of interest that large IL tumors also develop in 95% of Rbϩ/Ϫ heterozygous mice (19) subsequent to a loss of the remaining wild-type RB allele (28) . Further, disruption of the p27 kip1 gene, whose protein product inactivates cyclin/cyclindependent kinase complexes, also caused selective neoplastic growth in the IL (17, 18) . These, together with the high incidence of spontaneous IL tumors in several mammalian species (36) , suggest that IL cells, for yet unknown reasons, are especially sensitive to loss of negative regulators of cell cycle progression.
In spite of the general notion that the IL is composed of homogeneous cells, two distinct subpopulations of melanotrophs have been identified that differ in secretory activity, staining properties and receptor expression (37) (38) (39) . The IL also contains several non-POMC expressing cells, including marginal, folliculo stellate and interstitial cells (40 -42), whose function is poorly understood. Microscopic and biochemical observations revealed that IL tumors in either POMC-Tag (16) or Rbϩ/Ϫ (19) heterozygous mice begin as multifocal nodules that progress into large tumors by clonal expansion. Given the heterogeneity of the IL and the polyclonal origin of IL tumors, the emergence of two cell lines with different properties was not unexpected. Yet, although both mIL cell lines were derived from transgenic mice with IL tumors, SV40 Tag was expressed only by mIL39 cells. Presumably, only the POMC-expressing mIL39 cells should drive the production of Tag, resulting in cell transformation. Therefore, it appears that mIL5 cells have originated from a cell other than melanotroph that became immortalized by a spontaneous mutation(s). Alternatively, mIL5 cells represent a stem cell or a dedifferentiated melanotroph that no longer expresses typical cellular markers. Future studies will explore cellular markers that might reveal the origin and identity of mIL5 cells
Pituitary hormone research has benefitted from the availability of immortalized cell lines such as the rat somatomammotroph GH 3 cells (43) and the ACTH-producing mouse AtT20 cells (44) . Cell lines provide a renewable homogeneous population of cells that can be manipulated under controlled conditions. Although both melanotrophs and corticotrophs produce POMC, they differ in their expression of POMC processing enzymes (24) , main secretory products (45) , and expression of receptors for glucocorticoids (46) , CRH (47) and dopamine D 2 receptors (26, 27) . Work is underway to determine whether mIL39 cells process POMC in a melanotroph-specific pattern and whether they secrete POMC peptides such as ␣MSH and ␤endorphin in a regulatable manner.
Regardless of its cellular origin or stage of differentiation, the mIL5 cell line has remained stable for many generations. In validation of PRF production by these cells, several criteria were fulfilled, including stimulation of PRL gene expression and release and lack of effect on GH. PRL release in response to coculture with mIL5 cells increased in both the somatomammotroph GH 3 cell line and primary rat AP cells. The robust stimulation of PRL gene expression and release by serum-free CM from mIL5 cells confirms that PRF is a secreted product, as would be expected from our in vivo demonstration that the IL participates in the control of PRL release (7, 8) . Furthermore, in support of our previous report (14) , the HPLC elution profile of PRF extracted from mIL5 cells resembles that extracted from primary IL tumors and differs from POMC products and known PRL secretagogues. Finally, the small size of the IL and the time-consuming task of producing sufficient IL tumors have made previous purification attempts an arduous task. Given the development of the PRF-producing cell line, the challenge of PRF isolation and structural determination should be finally met. FIG. 9 . Elution profile of PRF activity from mIL5 cell extracts on analytical reverse phase C-18 HPLC column. Fractionation was performed using 0.1% trifluoroacetic acid and an increasing gradient of AcN from 0 -60% over 60 min at 1 ml/min. Pooled aliquots from every four fractions were analyzed for PRF activity using GH 3 /luc cells. Top panel, Optical density (OD) at 220 nm. PRF activity eluted as one major peak (45-48% AcN) and a minor peak (38 -40% AcN), as shown by increased luciferase activity (middle panel) and PRL release (lower panel). Each value is a mean Ϯ SEM of four replicates.
